Angioplasty Balloons: Rising Peripheral and Coronary Interventions to Propel the Market by 2025

The global angioplasty balloon market size is expected to reach USD 2.9 billion by 2025, according to a new report by Grand View Research, Inc. The market is projected to record a CAGR of 3.3% during the forecast period. This growth is attributed to favorable government policies and increasing coronary and peripheral interventions. Angioplasty is a minimally invasive procedure, hence patients and surgeons prefer this procedure over high-cost stent placements. Furthermore, advancements in angioplasty balloons and expanding geographical reach are likely to propel the market growth in the coming years.

For instance, in December 2014, Medtronic plc received an FDA approval for their drug-coated balloon IN.PACT Admiral for the treatment of peripheral artery disease. The company also received product approval from Japanese Ministry of Health, Labor and Welfare for the treatment of peripheral artery disease in the upper leg. Approval and commercialization of cutting and scoring balloons, such as TREK and MINI TREK, AngioSculpt, and Flextome balloons along with rising adoption of new balloons are likely to drive the market further.

 To request a sample copy or view summary of this report, click the link below: 

https://www.grandviewresearch.com/industry-analysis/angioplasty-balloons-market

Further key findings from the study suggest:

• Normal balloon segment led the market in 2017 due to low costs and ability of these products to treat coronary artery obstruction
• DEBs are anticipated to be the fastest-growing segment during the forecast period due to lower restenosis rate and increased R&D investments by major companies
• Coronary vascular disease segment led in 2017 and is expected to maintain its dominance during the forecast period due to rising cases of coronary artery diseases
• Ambulatory surgery centers (ASCs) led the end use segment in 2017 as they help minimize the medical expenses and hospital stay
• North America was the dominant regional market the market in 2017 and is expected to maintain its position during the forecast period due to the presence of major companies
• Asia Pacific is anticipated to be the fastest-growing region during the forecast period due to rising healthcare expenditure and R&D investments by key companies
• Some of the prominent companies in the industry are Abbott Laboratories; Boston Scientific Corp.; Cardinal Health (Cordis); Cook Medical, Inc.; Becton Dickinson. and Company (C.R. Bard); ENDOCOR GmbH; Medtronic PLC; Spectranetics Corp.; and Johnson & Johnson

Diaphragm Pump Market Outlook By Size, Share, Latest Trends, And Key Players Up To 2025

The global diaphragm pumps market size is anticipated to reach USD 7.32 billion by 2025, according to a new report conducted by Grand View Research, Inc. The market is estimated to witness a CAGR of 5.5% during the forecast period. High demand for fresh water due to growing population and industrialization across the globe is projected to boost the market development over the coming years. Rapid infrastructural development and urbanization along with technological developments are the major reasons behind augmenting the demand for energy fuels resulting in a rise in oil & gas and power sector. This factor is also expected to boost the demand for diaphragm pumps in the years to come.

On the basis of operations, the market is segmented into single acting and double acting diaphragm pumps. In terms of revenue, the double acting diaphragm pump segment was valued at USD 3.82 billion in 2017 and is projected to hold the largest market share over the forecast period. Chemical & petrochemical end use segment witnessed a steady growth in 2017 and is expected to reach USD 1.20 billion over the forecast period. Chemical industry faces greater challenges as fluids, which are to be transferred, have numerous properties and diaphragm pumps have a capability to handle all types of fluids like flammable, volatile, abrasive, and viscous. Thus, the product is anticipated to witness high demand in the chemical & petrochemical industry.

In terms of mechanism, air operated diaphragm pump segment market was valued at USD 3.14 billion in 2017 and is expected to witness robust growth over the period of forecast. Growing adoption of these pumps across diverse applications including chemical, oil & gas, and mining is likely to supplement the segment expansion by 2025. China had the major chunk of the global market share in 2017. The region is expected to witness rapid growth over the next few years on account of its highest population and resultant demand for energy fuel and fresh water estimated.

 To request a sample copy or view summary of this report, click the link below: 

https://www.grandviewresearch.com/industry-analysis/diaphragm-pump-market

Further key findings from the study suggest:

• U.S. region is projected to expand at a strong CAGR over the forecast period. The Department of Energy introduced new energy conservation standards for manufacturers
• Thus, production of highly-efficient pumps is projected to augment the region’s growth in coming years
• U.K. region is projected to have a strong growth over the forecast period Implementation of stringent governmental policies and demand in wastewater treatment are driving the regional market
• Electrically operated pump segment is projected to witness lucrative growth in the forecast period
• High adoption, coupled with low operational costs of electrically operated pumps is projected to drive the market over the forecast period

Needle-free drug delivery device Market Opportunities, Future Guidelines, Value Chain Forecast To 2025

The global needle-free drug delivery device market size is poised to reach USD 16.27 billion by 2025, according to a new report by Grand View Research, Inc., progressing at a CAGR of 10.5% during the forecast period. Rising usage of injections in healthcare settings such as hospitals, clinics, and ambulatory surgical centers has led to spread of infectious diseases such as Hepatitis B, Hepatitis C, and AIDS, especially in developing countries. This acts as a key driver for the needle-less drug delivery devices industry. Furthermore, rising collaborations between market players is further likely to increase competitiveness of this market. For instance, PharmaJet and Mundipharma entered into a partnership in 2018 for distributing its needle free injectors over 120 markets globally.

Moreover, technological advancements in healthcare are expected to open new avenues for market players in applications such as cancer, AIDS, and Ataxic Cerebral Palsy. For instance, polycarbonate materials are being utilized in needle free injectors owing to their advantages such as design flexibility, toughness, light weight, and process ability. The most recent example of such technology is needle-free injection insulin delivery device manufactured by QS Medical Technology Co. (QS) in September 2018.

 To request a sample copy or view summary of this report, click the link below: 

https://www.grandviewresearch.com/industry-analysis/needle-free-drug-delivery-devices-market

Further key findings from the report suggest:

• Novel needle-less devices accounted for a significant share of more than 25.00% in 2017 owing to their wide array of applications
• Based on applications, the vaccine delivery segment is estimated to exhibit a lucrative growth rate over the forecast period due to its increasing usage for pediatric patients
• North America held the dominant share in the global arena in 2017, due to favorable government insurance policies and increased investments in R&D by healthcare companies
• For instance, In May 2018, U.S. Congress approved “right to try” bill where patients can try unproven medical treatments and devices in case of serious illness such as orphan diseases, including NETs
• The Asia Pacific needle-free medication transportation devices industry is anticipated to witness significant growth during the same period due to rising healthcare expenditure and growing investments by many companies in the healthcare sector
• Additionally, several countries in this region are implementing laws that cater to adoption of medical devices. For instance, the Korea-U.S. Free Trade Agreement (KORUS FTA) was implemented on March 15, 2012, in which most of the medical devices in Korea were made duty free
• Some of the key companies present in the market are Antares Pharma; Injex Pharma Ag; Verdict Media Limited; Valeritas, Inc.; and 3M Company
• Industry participants are involved in extensive research activities to develop novel needless drug delivery injectors for applications such as pain management, insulin drug delivery, and vaccines delivery.

Bowel Management Systems Market Size, Status, Share And Forecast 2018-2025

The global bowel management system market is expected to reach USD 2.25 billion by 2025, according to a new report by Grand View Research, Inc., expanding at a CAGR of 3.3% during the forecast period. Rising incidence of fecal incontinence coupled with growing government initiatives to raise awareness about bowel management is likely to drive the market. Furthermore, favorable reimbursement scenario has also been favoring the growth of the market.

Bowel management systems are an important tool to manage fecal incontinence. According to the International Foundation for Gastrointestinal Disorders, fecal incontinence affects 6.9% of adult females and 7.4% of adult males. It has also been estimated that around 20.0% of people with irritable bowel syndrome have bowel incontinence.

In addition, different organizations such as United Ostomy Associations of America, Inc. and Colostomy U.K. are working towards raising awareness about ostomy. They are focused on empowering and supporting people who have had ostomy. Also, government bodies globally are introducing programs to provide support to individuals with a stoma by improving access to clinically appropriate and most suitable stoma-related products. These are some of the factors that are promoting the growth of the market.

 To request a sample copy or view summary of this report, click the link below: 

https://www.grandviewresearch.com/industry-analysis/bowel-management-systems-market

Further key findings from the report suggest:

• Colostomy bags were the largest segment in 2017 and are likely to witness the fastest growth over the forecast period due to factors such as their high usage rate and well-structured reimbursement policies across developed regions
• The adult segment dominated the market in terms of revenue in 2017 owing to factors such as high prevalence of fecal incontinence among adults
• The home care segment was the leading segment in the market in 2017, owing to rising adoption of bowel management products in home care settings. The segment is also poised to witness the highest CAGR during the forecast period
• North America and Europe accounted for sizeable cumulative share in the market in 2017. These regions experience high usage rate of bowel management systems and are marked by presence of significant key players such as 3M and Medtronic
• Asia Pacific is expected to exhibit the fastest growth during the forecast period due to unmet clinical needs and need for better diagnosis
• Some of the prominent players operating in this space are Mederi Therapeutics Inc.; Aquaflush Medical Limited; Medtronic; Coloplast; C.R. Bard; 3M; Consure Medical; B. Braun; Cogentix Medical; ConvaTec; Axonics Modulation Technologies; Welland Medical Limited; MBH-International A/S; and Wellspect HealthCare
• Key players are adopting strategies such as expanding their geographic reach, increasing R&D activities, rising number of collaborations, growing awareness programs, technological advancements, and launching new products to increase their market share.

Cervical Cancer Treatment Market : Cost Analysis, Strategy and Growth Factor upto 2028

The global cervical cancer treatment market size is expected to reach USD 10.6 billion by 2025, according to a new report by Grand View Research, Inc. The market is projected to record a CAGR of 5.0% over the forecast period. Increased treatment penetration and rising disease incidence are projected to drive the market growth over the next few years. Although, sexually transmitted HPV is a major cause, the disease can also be triggered by other factors, such as oral contraceptives, multiple sexual partners, smoking, and HIV infection. There are more than 100 strains of HPV, 13 of which are high-risk or cancerous. Squamous cell carcinoma is the most common type and it accounts for nearly 85% of the overall cases.

The differentiation between squamous cell carcinoma and adenocarcinoma is based on the histology, as observed under the microscope. Cervical adenosquamous carcinoma is rare, involving a mixture of squamous and glandular tissues. Products for cervical cancer can be broadly classified into prevention and treatment. Preventive options involve vaccines against HPV. Currently, there are two commercial vaccines – Gardasil and Cervarix. Treatment options include biologics, such as Avastin and generics like topotecan, cisplatin, bleomycin, fluorouracil, paclitaxel, carboplatin, and doxorubicin. The development of targeted therapeutics with improved efficacy and reduced cost remains a key unmet need of this market. Nevertheless, expanding focus on the research and development in oncology, including cervical cancer, indicate a promising future for this market.

 To request a sample copy or view summary of this report, click the link below: 

https://www.grandviewresearch.com/industry-analysis/cervical-cancer-treatment-market

Further key findings from the study suggest:

• HPV affects nearly 95% of all cervical cancer cases. HPV strains 16 and 18 account for nearly 70% of all cases reported
• Nearly three-fourth of all cases occur in developing and underdeveloped regions (mostly, in Asia and Africa), where healthcare facilities are limited and awareness about diagnosis and treatment is low
• North America was the dominant region in the global cervical cancer treatment market and is expected to continue its dominance over the estimated period
• This growth is attributed to growing target population patient, increasing market penetration of drugs, and easy accessibility to advanced treatments
• Some of the key companies in the market include F. Hoffmann-LA Roche AG; Merck & Co., Inc.; GlaxoSmithKline PLC; Allergan PLC; Pfizer, Inc.; Biocon Ltd.; Bristol-Myers Squibb Company; AstraZeneca PLC; and Eli Lilly & Co.
• Merck & Co. led the competitive space and is likely to continue to be the largest shareholder due to strong commercial performances of Gardasil and Keytruda

Surgical Microscopes With Emerging Trends, Product Scope, and Demand Between 2018 to 2025

The global surgical microscopes market size is expected to reach USD 1.3 billion by 2025, according to a new study by Grand View Research, Inc. It is anticipated to register a CAGR of 11.5% over the forecast period. Prevalence of chronic disorders such as cancer and Coronary Heart Disease (CHD) requires surgery as the prime line of treatment. With the advent of operating microscopes, these surgeries have become easier and less painful; thus, these devices are a preferred choice for the treatment of chronic conditions. This factor is anticipated to bode well for market growth in near future.

The inflow of technologically-advanced products is projected to spur the demand for surgical microscopes as they are accurate and offer better illumination and stability. Technologies such as red reflex illumination stability, wide angle illumination, and augmented microscopy act as emerging technologies. Rising popularity of minimally invasive surgeries due to their patient-friendly nature is an impact rendering driver for this market. Operating microscopes are vital elements of minimally invasive procedures as well as microsurgeries, fueling growth of the surgical microscopes market.

Mergers and acquisitions along with new product launches are some of the key strategic initiatives undertaken by market players to sustain the competition. Upgrading of products, new launches, technological innovation, and strategic collaborations are the key initiatives. For instance, in August 2014, Alcon acquired WaveTec Vision, a developer of an intraoperative guidance system for cataract. This initiative helped Alcon to strengthen product portfolio in the ophthalmic surgical market.

 To request a sample copy or view summary of this report, click the link below: 

https://www.grandviewresearch.com/industry-analysis/surgical-microscopes-market

Further key findings from the study suggest:

• Oncology held lucrative market share in the application segment in 2017, owing to rising prevalence of cancer along with the complexity of treatment
• Neurosurgery and spinal surgeries are anticipated to witness lucrative growth over the forecast period, owing to increasing R&D investments
• The surgical microscopes based on casters are expected to continue leading the type segment over the forecast period, due to their portability and easy cleaning capabilities
• Hospital, as an end-user segment, held the largest market share in 2017. Greater financing capabilities and increased volume of surgeries contributed to this growth
• Physician’s/dentists’ clinic as end-user is anticipated to expand at a substantial CAGR, owing to the availability of small-scale microscopes and growth of cosmetic dentistry
• North America held lucrative market shares of around 39.0% in 2017. On the contrary, Asia Pacific is anticipated to witness lucrative growth over the forecast period. Unmet needs of huge population base along with economic development in this region governed its growth
• The key players operating in the surgical microscopes market include Carl Zeiss, Leica Microsystems, Allition (Wuzhou), Takagi Corporation, Topcon, Alcon, HAAG-STREIT SURGICAL, and Seiler Precision Microscopes.

Sports Nutrition Market Aspects, Overview and Scope 2018 to 2025

The global sports nutrition market size is expected to reach USD 24.43 billion by 2025, expanding at a CAGR 9.7% over a forecast period, according to a new report by Grand View Research, Inc. The market is majorly driven by growing demand for these products among sportsperson and athletes, rising consumer awareness, and increasing number of gyms and health & fitness centers across the globe that are involved in marketing of these nutritional products.

Increasing number of research activities in the field and new product launches are some of the major factors contributing to market growth. Presence of large market players is facilitating widespread product availability, which in turn is likely to stir up the demand for these products. For instance, in 2018, Amazon launched a private label sports supplement brand called OWN PWR for U.S. consumers. Glanbia Plc; Hormel Foods Corporation; General Nutrition Centers, Inc.; and Abbott are the major competitors operating in this market.

Growing consumer base, rapid pace of urbanization, and increasing disposable income of households are among the key trends escalating the growth of the market. Furthermore, widening base of health conscious population, rising incidence of sedentary diseases, and favorable government initiatives towards health promotion are anticipated to foster the growth of the market over the coming years.

 To request a sample copy or view summary of this report, click the link below: 

https://www.grandviewresearch.com/industry-analysis/sports-nutrition-market

Further Key Findings From the Report Suggest:

• The sports supplements segment is expected to experience the fastest CAGR of 10.5% over the forecast period owing to increasing health awareness among population and trend of self-diagnosis
• In 2017, bricks and mortar accounted for the largest revenue share in terms of distribution channel. However, e-commerce is poised to exhibit a lucrative CAGR of 12.4% over the forecast period
• North America represented the leading revenue share in 2017 owing to a large number of gyms and health & fitness centers and favorable initiatives encouraging sports participation
• Asia Pacific is projected to witness the highest CAGR of 13.0% over the forecast period
• The market is fairly competitive in nature with presence of key players including Glanbia Plc; Hormel Foods Corporation; General Nutrition Centers, Inc.; Abbott and Cardiff Sports Nutrition LTD; Nature’s Bounty; POST HOLDINGS, INC.; and Clif Bar & Company.

Needles Market to Witness a Pronounce Growth During 2025

The global needle market size is expected to reach USD 9.96 billion in 2025 according to a new report by Grand View Research, Inc. The market is projected to witness a CAGR of 6.6% over the forecast period. Rising awareness regarding blood donation along with extensive R&D to develop advance needle technology with maximum safety and precision is expected to contribute to the market expansion in the years to come. The conventional needles segment led the global needle market in 2017, in terms of revenue share.

The safety needles segment is expected to witness the fastest CAGR during the forecast period due to reduced risk of needle stick injuries. Blood collection needles segment held a significant share of the global market in 2017 due to increasing awareness about blood donation and stringent regulations on blood screening. For instance, tests, such as Nucleic Acid Amplification Test (NAT) and ELISA, are mandatory in European countries including France, Germany, Spain, Italy, U.K., and Switzerland.

 To request a sample copy or view summary of this report, click the link below: 

https://www.grandviewresearch.com/industry-analysis/needles-market

Further key findings from the study suggest:

• Hypodermic needles segment accounted for the majority share of the market in 2017. While, intravenous needles are likely to experience the fastest growth in the coming years
• Stainless steel needles led the material segment in 2017 These needles have tough structure and high strength and resistance to corrosion
• Europe held the largest market share in 2017 due to faster regulatory approvals of innovative devices and procedures
• Asia Pacific is expected to be the fastest-growing regional market owing to increasing healthcare infrastructure and expenditure
• Becton, Dickinson and Company; Stryker Corp.; Medtronic PLC; Ethicon, Inc.; Novo Nordisk A/S; Thermo Fisher Scientific, Inc.; Boston Scientific Corp.; Smiths Medical, Inc.; and Hilgenberg GmbH are some of the key companies in the global market

U.S. Chiropractic Market Regulations and Competitive Landscape Outlook to 2025

The U.S. chiropractic market size is expected to reach USD 17.93 billion by 2025, according to a new report by Grand View Research, Inc. The market is projected to witness a CAGR of 4.32% during the forecast period. Rising cases of back, shoulder, foot, neck pain, and headaches are driving the chiropractic market in the country. This is expected to help in revenue generation. Other factors such as increasing number of chiropractors in the country would help in the market growth. The majority of people suffering from lower back pain and other such issues initially seek help from a chiropractor.

This has resulted in healthy growth in the chiropractic practices. Furthermore, it has also exhibited steadily increasing acceptance by doctors, third-party payers, and the federal government apart from patients. These factors are expected to support the market expansion. As per the American Chiropractic Association, it is estimated that by 2020, there would be ~80,000 chiropractors in the country with an addition of over ~2500 new practitioners each year graduating from colleges. Chiropractors treat an approximate 35 million patients each year in the country, which has contributed to making the U.S. chiropractic industry a significant one.

 To request a sample copy or view summary of this report, click the link below: 

https://www.grandviewresearch.com/industry-analysis/us-chiropractic-market

Further key findings from the study suggest:

• The market is driven by increasing number of patients seeking complementary medical treatments rather than approved medicine
• Franchising offers a ready-source of marketing, financing, and awareness for a new entrant to establish a clinic. Moreover, it also helps the existing practitioners to expand their business
• Authorization of different set of laws for chiropractic treatment is also supporting the U.S. chiropractic market growth. This encourages more chiropractors to set up businesses
• There are currently 10,000 chiropractic students in 18 nationally accredited, doctoral graduate education programs for chiropractic therapy of which ~2500 will enter the workforce every year
• In 2017, 95% of the past-year chiropractic users cited this therapy as an effective mode of treatment. Furthermore, 97% of the users have reported to visit chiropractors if they have back/neck pain
• Some of the active institutes that offer chiropractic services in the U.S market are Magen David Community Center, Inc.; The Joint Corp.; Lbi Starbucks DC 3; Allied Health of Wisconsin, S.C., P.C.; Sherman College of Straight Chiropractic, Inc.; Chiropractic Strategies Group, Inc.; Chiro One Wellness Centers, LLC; Landmark Healthcare Services, Inc.; Parsons Gregory V Advanced Chiropractic Clinic; Silverman Chiropractic Center; Emergency Chiropractic PC; Multi-Specialty Healthcare Group, LLC.

Healthcare Market Detail Analysis , Share And Size, Trends, Industry Growth And Segment Forecasts To 2026

The global healthcare reimbursement market size is expected to reach USD 20.45 trillion by 2026, according to a new report by Grand View Research, Inc., exhibiting a CAGR of 19.0% during the forecast period. Supportive government initiatives along with rising cost of prescription medicines are likely to work in favor of the market.

The U.S. Affordable Care Act focuses on controlling and minimizing costs of healthcare. The law supports innovative methods to deliver medical care to reduce healthcare costs and makes affordable health insurance available to more people. Since the Obamacare came into effect in 2014, the number of uninsured children under the age of 18 in the U.S. reduced to 5.0% in 2015 as compared to 9% in 2008.

In addition, the Centre for Medicare & Medicaid Services is working towards delivery of reliable high-quality care, endorsement of efficient results in healthcare system, and making health insurance affordable for millions of Americans who are seeking and getting coverage. The Medicaid spending in the U.S. grew by 3.9% in 2016 or 17.0% of the total National Health Expenditure. And Medicare spending grew by 3.6% in 2016 or 20.0% of the total National Health Expenditure.

The underpaid segment is anticipated to dominate the market through 2026 owing to growing cases of frauds against government healthcare programs and increasing use of healthcare services that are not medically required. There have been several cases where businesses and individuals have defrauded federal and state government healthcare programs by submitting false claims for healthcare services, treatment, pharmaceutical, and medical devices that were never rendered.

Also, the rivalry among healthcare providers and rising pressure from commercial and public payers to reduce costs as well as to improve care are shifting their focus towards value-based care models from volume-based healthcare models.

 To request a sample copy or view summary of this report, click the link below: 

https://www.grandviewresearch.com/industry-analysis/healthcare-reimbursement-market

Further Key Findings from the Report Suggest:

• Underpaid emerged as the largest segment in 2017 owing to increasing number of insurance plans that do not cover full reimbursement
• On the basis of payers, private players accounted for the leading share in the market in 2017 owing to presence of a large number of private players
• North America dominated the market in 2017. A raft of insurance players and strong reimbursement framework are facilitating the dominance of the region
• The market in Asia Pacific is projected to witness rapid growth during the forecast period owing to rising penetration of insurance services in rural and urban areas
• Some of the market players are UnitedHealth Group, Allianz, Aviva, Aetna, Nippon Life Insurance, CVS Health, WellCare Health Plans, BNP Paribas, The Blue Cross Blue Shield Association, and AgileHealthInsurance.

U.S. Revenue Cycle Management (RCM) Market 2019: Industry Status, Sales Outlook, Supply-Demand Study 2025

The U.S. revenue cycle management (RCM) market size is expected to reach USD 25.63 billion by 2025, according to a new report by Grand View Research, Inc. It is anticipated to expand at a CAGR of 11.2% over the forecast period. Supportive government reforms along with growing need for optimization of the organizational workflow will propel the market growth.

Government reforms, such as the Affordable Care Act (ACA) U.S. focused on expanding health insurance coverage to individuals with low income, improving the quality of healthcare services, and reducing healthcare costs are playing a crucial role in boosting the adoption of Revenue Cycle Management (RCM) systems. Furthermore, the expanding insurance coverage is projected to increase the reimbursements as well as denials that are required to be managed through RCM. Therefore, the demand for systems that can efficiently manage reimbursement processes is expected to increase.

In addition, the Health Information Technology for Economic and Clinical Health (HITECH) Act promotes the adoption of certified EHR systems in U.S., which is anticipated to bode well for the growth of the market in near future. Implementation of Stage 3 of the Medicaid and Medicare EHR Incentive Programs in 2015 that promoted the adoption of Healthcare IT systems to improve healthcare quality, is also contributing to the U.S. revenue cycle management market.

Several healthcare providers across the country are undertaking initiatives to facilitate health data exchange and improve the efficiency of healthcare systems. For instance, the initiative taken by healthcare providers to use paperless healthcare systems and incorporate HIT systems by 2020 is likely to boost the U.S. market growth during the forecast period.

 To request a sample copy or view summary of this report, click the link below: 

https://www.grandviewresearch.com/industry-analysis/us-revenue-cycle-management-rcm-market

Further key findings from the report suggest:

• Integrated software emerged as the largest segment owing to factors, such as growing number of healthcare facilities, need for improved efficiency of healthcare systems, and elimination of human errors
• Cloud-based segment is projected to witness the fastest growth over the forecast period owing to the flexibility and scalability offered by cloud-based solutions
• Physician’s office dominated the market in 2017, owing to rising usage by the physicians’ staff and office managers to facilitate smooth functioning of their units
• Some key players in the U.S. revenue cycle management market are SSI Group; Allscripts, Cerner Corporation; McKesson Corporation; athenahealth, Inc.; Epic Systems Corporation; eClinicalworks; NextGen Healthcare Information System; CareCloud Corporation; Quest Diagnostics; and Kareo, Inc.